ADMA Biologics Inc (ADMA) Social Stream
ADMA BIOLOGICS INC (ADMA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ADMA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 5 | $10 | $3 | $5.7 | $4.4 | 29.55% |
| 2021-11-11 | 5 | $10 | $3 | $5.7 | $4.4 | 29.55% |
| 2022-01-06 | 4 | $10.001 | $3 | $5.7 | $4.4 | 29.55% |
| 2022-03-24 | 4 | $8 | $3 | $5.3 | $4.4 | 20.45% |
| 2022-03-28 | 3 | $8 | $3 | $5.3 | $4.4 | 20.45% |
| 2022-05-12 | 2 | $6 | $3 | $4.625 | $4.4 | 5.11% |
| 2022-07-25 | 3 | $5 | $4 | $4.5 | $4.4 | 2.27% |
| 2022-08-11 | 3 | $5 | $4 | $4.666 | $4.4 | 6.05% |
| 2022-10-13 | 4 | $5 | $4 | $4.75 | $4.4 | 7.95% |
| 2022-11-11 | 3 | $6 | $4 | $5 | $4.4 | 13.64% |
| 2022-12-12 | 4 | $6 | $4 | $5 | $4.4 | 13.64% |
| 2023-07-11 | 4 | $6 | $4.5 | $5.166 | $4.4 | 17.41% |
| 2023-07-18 | 4 | $6 | $4.5 | $5.125 | $4.4 | 16.48% |
| 2023-08-10 | 4 | $7 | $5 | $5.75 | $4.4 | 30.68% |
| 2023-11-10 | 4 | $7 | $5 | $6 | $4.4 | 36.36% |
The Trend in the Analyst Price Target
Over the past 20 months, ADMA's average price target has gone up $1.38.
Over the past 42 weeks, ADMA's average upside potential has been 45.96%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-11 | 4 | 6 | 4.5 | 5.125 | 3.55 | 44.37% |
| 2023-07-11 | 4 | 6 | 4.5 | 5.166 | 3.55 | 45.52% |
| 2023-07-18 | 4 | 6 | 4.5 | 5.125 | 3.57 | 43.56% |
| 2023-08-10 | 4 | 7 | 5.0 | 6.000 | 4.31 | 39.21% |
| 2023-08-10 | 4 | 7 | 5.0 | 5.750 | 4.31 | 33.41% |
ADMA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
ADMA's average broker recommendation rating improved by 0 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADMA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ADMA BIOLOGICS INC's average analyst price target is greater than 59.38% of them.
- In terms of how ADMA BIOLOGICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 159.53% of that group.
- ADMA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 297.04% of Pharmaceutical Products stocks.
- In terms of how ADMA BIOLOGICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -385.7% of that group.
Stocks similar to ADMA BIOLOGICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VXRT, PSTX, and TARS.
View All Top Stocks by Price Target
Make investment decisions regarding ADMA using the data that counts. Try POWR Ratings for free.